Literature DB >> 10756248

Validity and reproducibility of echocardiographic measurement of left ventricular ejection fraction by acoustic quantification with tissue harmonic imaging technique.

Y Tsujita-Kuroda1, G Zhang, Y Sumita, K Hirooka, A Hanatani, S Nakatani, Y Yasumura, K Miyatake, M Yamagishi.   

Abstract

The tissue harmonic imaging technique can enhance detection of the cardiac endocardial border. When combined with an acoustic quantification (AQ) method, an improvement of accuracy and reproducibility of real-time measurement of left ventricular (LV) function might be expected. However, few data exist regarding the measurement of LV function by AQ with the harmonic imaging technique. Therefore, we evaluated the validity and reproducibility of AQ measurement of LV ejection fraction with or without harmonic imaging technique. A total of 50 patients (mean age 58 +/- 10 years) who underwent left ventriculography were included in our study. The LV end-diastolic and end-systolic volumes by ventriculography were 131 +/- 52 mL and 72 +/- 43 mL, respectively, and were underestimated by both conventional (70 +/- 32 mL and 36 +/- 25 mL) and harmonic (67 +/- 30 mL and 34 +/- 22 mL) AQ obtained in the apical 4-chamber view. The calculated ejection fraction by ventriculography was 0.49 +/- 0. 11 and correlated with that by conventional AQ (0.51 +/- 0.11; y = 0. 72x + 0.152; r = 0.73). This was a marked improvement when compared with the ejection fraction by harmonic AQ (0.50 +/- 0.11; y = 0.89x + 0.065; r = 0.91). Interestingly, interobserver and intraobserver variabilities of conventional AQ, which were 15.6% and 8.6%, respectively, were much improved by harmonic AQ (8.9% and 4.5%, respectively). These results indicate the feasibility of real-time measurement of LV ejection fraction by harmonic imaging, although absolute LV volume can be underestimated even by this technique.

Entities:  

Mesh:

Year:  2000        PMID: 10756248     DOI: 10.1067/mje.2000.103962

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  6 in total

1.  An enhanced method for left ventricular volume and ejection fraction by triggered harmonic contrast echocardiography.

Authors:  K Hirooka; Y Yasumura; Y Tsujita; A Hanatani; S Nakatani; K Miyatake; M Yamagishi
Journal:  Int J Cardiovasc Imaging       Date:  2001-08       Impact factor: 2.357

Review 2.  Assessment of ventricular function and mass by cardiac magnetic resonance imaging.

Authors:  Khaled Alfakih; Scott Reid; Tim Jones; Mohan Sivananthan
Journal:  Eur Radiol       Date:  2004-07-17       Impact factor: 5.315

3.  Parametric harmonic-to-fundamental ratio contrast echocardiography: a novel approach to identification and accurate measurement of left ventricular area under variable levels of ultrasound signal attenuation.

Authors:  Shiro Yoshifuku; Shigao Chen; Eileen M McMahon; Akiko Yoshikawa; Partho P Sengupta; Josef Korinek; Marek Belohlavek
Journal:  Ultrasonics       Date:  2006-12-21       Impact factor: 2.890

4.  Wall motion changes in myocardial infarction in relation to the time elapsed from symptoms until revascularization.

Authors:  Ildikó Rácz; László Fülöp; Rudolf Kolozsvári; Gábor T Szabó; Annamária Bódi; Andrea Péter; Attila Kertész; Ida Hegedüs; István Édes; László Balkay; Zsolt Köszegi
Journal:  Anatol J Cardiol       Date:  2014-07-11       Impact factor: 1.596

5.  Effect of acute hyperglycemia on left ventricular contractile function in diabetic patients with and without heart failure: two randomized cross-over studies.

Authors:  Roni Nielsen; Helene Nørrelund; Ulla Kampmann; Hans Erik Bøtker; Niels Møller; Henrik Wiggers
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

6.  Diagnostic value of harmonic transthoracic echocardiography in native valve infective endocarditis: comparison with transesophageal echocardiography.

Authors:  Davinder S Jassal; Amin Aminbakhsh; Tielan Fang; Nasir Shaikh; John M Embil; Gordon S Mackenzie; James W Tam
Journal:  Cardiovasc Ultrasound       Date:  2007-05-19       Impact factor: 2.062

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.